APA (7th ed.) Citation

Ahmad, W., Choe, K., Choe, K., Ahmad, R., Park, T. J., Kim, M. O., & Kim, M. O. (2025). Ambroxol confers neuroprotection against scopolamine-induced Alzheimer’s-like pathology by modulating oxidative stress, neuroinflammation, and cognitive deficits via Nrf-2/JNK/GSK-3β signaling pathways. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Ahmad, Waqas, Kyonghwan Choe, Kyonghwan Choe, Riaz Ahmad, Tae Ju Park, Myeong Ok Kim, and Myeong Ok Kim. Ambroxol Confers Neuroprotection Against Scopolamine-induced Alzheimer’s-like Pathology by Modulating Oxidative Stress, Neuroinflammation, and Cognitive Deficits via Nrf-2/JNK/GSK-3β Signaling Pathways. Frontiers Media S.A, 2025.

MLA (9th ed.) Citation

Ahmad, Waqas, et al. Ambroxol Confers Neuroprotection Against Scopolamine-induced Alzheimer’s-like Pathology by Modulating Oxidative Stress, Neuroinflammation, and Cognitive Deficits via Nrf-2/JNK/GSK-3β Signaling Pathways. Frontiers Media S.A, 2025.